Status:
COMPLETED
Study of Tomotherapy in Patients With Benign Brain Tumour
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Brain Neoplasms
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Although malignant brain tumors are the most common type of primary brain tumor, there are a number of other benign brain tumors that exist. Many difficulties exist with treating these tumors that hav...
Eligibility Criteria
Inclusion
- Histopathologically confirmed newly diagnosed base of skull benign tumour
- Karnofsky Performance Status (KPS) equal to or greater than 70
Exclusion
- Brain metastases or recurrent tumour
- Prior radiotherapy (RT) to head or neck
- No prior chemotherapy or radiosensitizer
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00128986
Start Date
May 1 2005
End Date
August 1 2014
Last Update
April 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2